Skip to search.
 STI Down0.09%

More On A61.SI

Quotes

Charts

News & Info

Company

  • Profile
  • Key Statistics
  • SEC Filings
  • Competitors
  • Industry
  • Components

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Luye Pharma Group Ltd. (A61.SI)

-SES

1.36 0.00(0.00%) 9 Oct 17:04 SGT

Add to Portfolio
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2011Dec 31, 2010Dec 31, 2009Dec 31, 2008
Total Revenue 1,774,000   1,341,000   955,000   651,000  
Cost of Revenue301,000  204,000  136,000  109,000  
Gross Profit 1,473,000   1,137,000   819,000   542,000  
Operating Expenses
Research Development -   -   -   -  
Selling General and Administrative -   -   -   -  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses1,556,000  1,158,000  800,000  569,000  
Operating Income or Loss 219,000   183,000   155,000   82,000  
Income from Continuing Operations
Total Other Income/Expenses Net -   -   -   -  
Earnings Before Interest And Taxes219,000  183,000  155,000  82,000  
Interest Expense(19,000)(10,000)(9,000)(13,000)
Income Before Tax -   -   -   -  
Income Tax Expense35,000  45,000  37,000  21,000  
Minority Interest(15,000)(14,000)(6,000) -  
Net Income From Continuing Ops166,000  150,000  129,000  62,000  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 152,000   136,000   124,000   62,000  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares -   -   -   -  

Currency in SGD.